DRUGS group AstraZeneca has dropped legal action plans against Merrill Lynch Investment Managers over the way the bank managed its pension fund. AstraZeneca was one of several companies to sack Merrill last year and said in November that it was considering taking legal action.
Create a FREE account to continue reading
Registration is a free and easy way to support our journalism.
Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.
Thank you for registering
Please refresh the page or navigate to another page on the site to be automatically logged in